
|Videos|November 18, 2017
Dr. Volpe Discusses the Management of Localized Kidney Cancer
Author(s)Alessandro Volpe, MD
Alessandro Volpe, MD, University of Eastern Piedmont Hospital, Maggiore Della Carita Hospital, Novara, Italy, discusses the management of locally advanced kidney cancer.
Advertisement
Alessandro Volpe, MD, University of Eastern Piedmont Hospital, Maggiore Della Carita Hospital, Novara, Italy, discusses the management of locally advanced kidney cancer.
The management of localized kidney cancer has significantly changed over the last few years, says Volpe. The standard of care for these patients is surgery, and when possible, nephron-sparing surgery.
Volpe says that many of the tumors end up being benign or very low risk, so active surveillance may be a suitable option for these patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5






































